Related Experiment Videos
[Update on a titration method for measuring the interferon-producing capacity in humans].
1Département de Microbiologie, Université Médicale de la Préfecture de Kyoto, Japan.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1989
Summary
This study introduces a simple whole blood method to measure interferon-alpha (IFN-alpha) production capacity. Cancer patients showed significantly lower IFN-alpha production compared to healthy donors.
Area of Science:
- Immunology
- Virology
- Clinical Diagnostics
Background:
- Interferon-alpha (IFN-alpha) plays a crucial role in antiviral and antitumor immunity.
- Assessing IFN-alpha production capacity is important for understanding immune status in various diseases.
- Existing methods for measuring IFN-alpha production can be complex and time-consuming.
Purpose of the Study:
- To develop and validate a simple, accessible method for measuring interferon-alpha (IFN-alpha) producing capacity in humans.
- To compare IFN-alpha production capacity between healthy donors and cancer patients.
- To evaluate the influence of age and sex on IFN-alpha production capacity.
Main Methods:
- Development of a whole blood method for IFN-alpha production assessment.
- Incubation of heparinized blood with Sendai virus at 37°C for 20 hours.
- Quantification of IFN activity using the cytopathic effect inhibition assay.
Main Results:
- The developed whole blood method proved effective for measuring IFN-alpha producing capacity.
- IFN-alpha production capacity was significantly lower in 130 cancer patients compared to 531 healthy donors.
- No significant differences in IFN-alpha production capacity were observed based on age or sex, despite individual variations.
Conclusions:
- The whole blood method is a simple and useful tool for measuring human IFN-alpha producing capacity.
- Reduced IFN-alpha production capacity may be associated with cancer.
- This method facilitates large-scale studies on immune responses and disease states.